Modulation of human platelet function by L-canavanine: Differential effects of low and high concentrations

General Pharmacology

Volumn 32, Issue 3, 1999, Pages 321-328

  Anfossi, Giovanni ^a   Massucco, Paola ^a   Mattiello, Luigi ^a   Cavalot, Franco ^a   Perna, Paolo ^a   Giori, Alessandra ^a   Tassone, Francesco ^a   Trovati, Mariella ^a  

^a Diabetes Unit   (Italy)

Author keywords

L Canavanine; Nitric oxide; Nitric oxide synthase inhibitors

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARGININE; CANAVANINE; CATECHOLAMINE; CYCLIC GMP; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; SEROTONIN;

ADULT; ARTICLE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ARGININE; BLOOD PLATELETS; CANAVANINE; CATECHOLAMINES; CYCLIC GMP; DRUG INTERACTIONS; HUMANS; NITRIC OXIDE SYNTHASE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; SEROTONIN;

EID: 0032970254     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00193-1     Document Type: Article

References (33)

1. Anfossi G., Trovati M. Role of catecholamines in platelet function. pathophysiological and clinical significance Eur J Clin Invest. 26:1996;353-370.
2. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
3. Bygdeman S., Johnsen O. Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine. Acta Physiol Scand. 75:1969;129-138.
4. Chirkov Y.Y., Belushkina N.N., Tyshchuk I.A., Severina I.S., Horowitz J.D. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside. Clin Exp Pharmac Physiol. 18:1991;517-524.
5. Davies T., Davidson M.M.L., McClenaghan M.D., Say A., Haslam R.J. Factors affecting platelet cyclic GMP levels during aggregation by collagen and by arachidonic acid. Thromb Res. 9:1976;387-405.
6. Fukuto J.M., Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase. potential selective inhibition Annu Rev Pharmac Toxicol. 35:1995;165-194.
7. G-nitroarginine. Biochemistry. 32:1993;8512-8517.
8. Haslam R.J., McClenaghan M.D. Effects of collagen and of aspirin on the concentrations of guanosine 3′,5′-cyclic monophosphate in human blood platelets. measurement by a prelabelling technique Biochem J. 138:1974;317-322.
9. Holmsen H. Platelet activation and serotonin. Vanhoutte P.M. Serotonin and the cardiovascular system. 1985;75-86 Raven Press, New York.
10. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmac. 211:1992;177-192.
11. Iyengar R., Stuehr D.J., Marletta M.A. Macrophage synthesis of nitrite, nitrate and N-nitrosoamines. precursors of the respiration burst Proc Natl Acad Sci USA. 84:1987;6369-6373.
12. Liaudet L., Feihl F., Rosselet A., Markert M., Hurni J.-M., Perret C. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia. Clin Sci. 90:1996;369-377.
13. Malinski T., Radomski M.W., Taha Z., Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun. 194:1993;960-965.
14. Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., Wishnok J.S. Macrophage oxidation of L-arginine to nitrite and nitrate. nitric oxide is an intermediate Biochemistry. 27:1988;8706-8711.
15. McCall T.B., Boughton-Smith N.K., Palmer R.M.J., Whittle B.J.R., Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. release and interaction with superoxide anion Biochem J. 261:1989;293-296.
16. McCall T.B., Feelisch M., Palmer R.M.J., Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide in phagocytic cells. Br J Pharmac. 102:1991;234-238.
17. McMillan D.C. Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature (Lond). 211:1966;140-144.
18. Mills D.C.B., Roberts G.C.K. Effects of adrenaline on human blood platelets. J Physiol (Lond). 193:1967;443-453.
19. Moncada S., Higgs E.A. Endogenous nitric oxide. physiology, pathology and clinical relevance Eur J Clin Invest. 21:1991;361-374.
20. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide. physiology, patho-physiology and pharmacology Pharmac Rev. 43:1991;109-142.
21. G-Nitroarginine (L-NOARG), a novel L-arginine-reversible inhibitor or endothelium-dependent vasodilation in vitro. Br J Pharmac. 99:1990;409-412.
22. Mustard J.F., Packham L.A., Kinlough-Rathbone R.L., Perry D.W., Regoeczi F. Fibrinogen and ADP-induced platelet aggregation. Blood. 52:1978;453-466.
23. Niewiarowski S., Holt J.C. Platelet α-granule proteins. biochemical and pathophysiological aspects Longenecker G.L. The platelets. physiology and pharmacology:1985;49-83 Academic Press, Inc, Orlando.
24. G-methyl-L-arginine. Biochem Biophys Res Commun. 177:1991;828-833.
25. Palmer R.M.J., Ashton A.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
26. Radomski M.W., Palmer R.M.J., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmac. 101:1987;325-328.
27. Radomski M.W., Palmer R.M., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:1990;5193-5197.
28. Sase K., Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 57:1995;2049-2055.
29. Schmidt H.H.H.W., Nau H., Wittfoht W., Gerlach J., Prescher K.-E., Klein M.M., Niroomand F., Bohme E. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmac. 154:1988;213-216.
30. 4. FEBS Lett. 244:1989;357-360.
31. Umans J.G., Samsel R.W. L-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur J Pharmac. 210:1992;343-346.
32. Weiss H.J., Rogers J. Thrombocytopenia due to abnormalities in platelet release reaction. Blood. 39:1972;2-8.
33. Zhou Q., Hellermann G.R., Solomonson L.P. Nitric oxide release from resting human platelets. Thromb Res. 77:1995;87-96.